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ndothelial dysfunction and a relative deficiency in nitric oxide (NO) may be associated with hypertension in humans 1, 2 and in some models of experimental hypertension. 3, 4 In the spontaneously hypertensive stroke-prone rat (SHRSP), a model of genetic hypertension, we have shown an attenuation of functional basal NO despite increased eNOS enzymatic activity. 5 Although endothelial NO synthase (eNOS) enzymatic activity was greater in SHRSP than in Wistar-Kyoto rats (WKY) when examined in vitro the possibility that the actual amount of eNOS was reduced in SHRSP in vivo could not be excluded from these results. Alternatively, eNOS levels could be similar or elevated but NO availability decreased because of more rapid removal after synthesis. Superoxide anion (O 2 Ϫ ) is produced in the vasculature and can scavenge NO forming peroxynitrite. Increased scavenging of NO by O 2 Ϫ could lead to a decrease in NO availability despite increased synthesis. Raised O 2 Ϫ levels have been reported recently in a number of models of endothelial dysfunction including hypertension, induced by either angiotensin infusion 6 or aortic banding. 7 In the majority of cases the source of excess O 2 Ϫ is uncertain, although involvement of NADH/NADPH oxidases 8 and xanthine oxidase 9 have been suggested.
The aim of this study was to examine the hypothesis that the decreased NO availability observed in SHRSP is due to excess O 2 Ϫ , to identify the source of this O 2 Ϫ , and to examine other molecular mechanisms involved such as the expression of the gene-encoding enzyme involved in NO generation in the endothelium (eNOS).
Methods Animals
Three-to 4-month-old male and female WKY and SHRSP were obtained from the colonies established in Glasgow by brother and sister mating as previously described. 9 Blood pressure was measured 1 week before study by tail plethysmography according to our published protocol. 10 
Superoxide Measurement
Animals were killed with barbiturate overdose. The abdominal aorta was removed and placed in chilled buffer. Periadventitial tissue was carefully removed and O 2 Ϫ quantified in 5-mm aortic segments with lucigenin chemiluminescence as originally described by O'Hara et al 11 and recently reassessed by Li and colleagues. 12 In some experiments the endothelium was removed by rubbing. Ϫ generation between thoracic and abdominal aortas from either WKY or SHRSP. 13 In this study abdominal aortas were taken for O 2 Ϫ measurement and thoracic aortas used to confirm the attenuation of basal NO 14 in the same animals and for quantification of the mRNA of eNOS.
Reverse Transcription-Polymerase Chain Reaction for eNOS
Total RNA was extracted from homogenized thoracic aortas with the use of RNAzol B. Messenger RNA for eNOS was quantified by reverse transcription-polymerase chain reaction (RT-PCR) as described. 15 Briefly, competitor RNA was transcribed in vitro from the plasmid pReNIS5, which was kindly donated by F. Soubrier (Paris, France). This plasmid contains a 64 bp fragment of polylinker inserted in the Sac II site of a rat eNOS cDNA.
Total aortic RNA (100 ng) and competitor RNA(0 to 400 fg) were reverse transcribed in the same reaction at 42°C for 45 minutes with oligo(dT) 15 primer (0.5 g/L) and Avian Myoblastosis Virus (AMV) reverse transcriptase (10 U/L) in the presence of RNase inhibitor (40 U/L). PCR was carried out on a 3-L aliquot of each RT reaction with the use of 2 primers, forward (5Ј-TTC CGG CTG CCA CCT GAT CCT AA-3Ј) and reverse (5Ј-AAC ATG TGT CCT TGC TCG AGG CA-3Ј) surrounding the 64 bp fragment insertion site. Each reaction contained Taq DNA polymerase (5 U//L), primers (10 mol/L each), and dNTPs (1.25 mmol/L) and was subjected to an initial denaturation at 94°C for 5 minutes, then 28 cycles of 30 seconds at 94°C, 30 seconds annealing at 62°C, and 1-minute elongation at 72°C, then completion of ongoing reactions at 62°C for 1 minute and 72°C for 10 minutes.
The products of each reaction were run on a 2% agarose gel and bands visualized by Southern blotting. The density of each band was quantified with a densitometer and a plot of long competitor density (x-axis) versus log ratio (target density/competitor density) (y-axis) constructed. When the log ratioϭ0, then the concentration target and competitor are equal, and this value can be read from the x-axis ( Figure 1 ). For each sample, 10 RT-PCR reactions were run with a range of amounts of competitor RNA in 40-fg increments around the target concentration.
Western Blotting
After the rats were killed, the thoracic aorta was removed and rapidly frozen in liquid nitrogen. The proteins were extracted by homogenization using a Kinematica polytron homogenizer (Philip Harris Scientific) in boiling 250 mmol/L Tris HCl pH 6.8, 4% SDS, 10% glycerol, 0.006% biomaphenol blue, and 2% ␤-mercapto ethanol. Protein (10 g) was electrophoresed on an SDS polyacrylamide gel. The proteins were transferred onto PVDF (polyvinyl difluoride) membrane overnight. Prestained Rainbow Markers (Amersham) were used as molecular mass standards. The membranes were blocked in 5% skimmed dried milk in 10 mmol/L Tris, pH 7.5, 100 mmol/L NaCl, 0.1% Tween 20 for 1 hour at room temperature. Thereafter they were incubated with antibodies directed against human eNOS (Transduction Laboratories) according to the manufacturer's instructions. Bands were detected by use of an enhanced chemiluminescence test (Amersham) and autoradiography by exposure to x-ray film (Kodak, X-OMAT). The blots were also incubated with an antibody against ␣-actin (Boehringer), and both sets of bands were quantified with the use of a Phospho-Imager (Molecular Dynamics).
Analysis of Data
Analysis was by unpaired t test or ANOVA as appropriate. Bonferroni correction was used when multiple comparisons were made. Results are expressed as meanϮSE.
Results

Blood Pressure
Blood pressure was elevated in SHRSP compared with WKY and in addition was significantly higher in males than females. Systolic blood pressure (mm Hg) was as follows: male WKY 131Ϯ3 (nϭ21); female WKY 123Ϯ2 (nϭ17); male SHRSP 171Ϯ6 (nϭ23); female SHRSP 149Ϯ3 (nϭ30).
Superoxide Levels
Superoxide levels were increased in SHRSP males and females compared with their WKY counterparts, as shown in Figure 2 . In addition, a gender difference was observed in WKY rats, with males having higher levels than females. However, although overall O 2 Ϫ generation was greater in male than female SHRSP (4.11Ϯ0.24 versus 3.84Ϯ0.28 nmol A constant amount of total RNA from rat aorta (target) was mixed with increasing amounts of internal standard mRNA (competitor), reverse transcribed, and amplified by PCR with eNOS specific primers. PCR products were run on a 2% (wt/vol) agarose gel, blotted onto nylon membrane, hybridized with an end-labeled primer as a probe, and exposed to photographic film. The density of each band was measured and the logarithm of the ratio (density of target/density of competitor) plotted against the logarithm of the known amount of competitor mRNA in each reaction. At the competition equivalence (log ratioϭ0), the amount of target mRNA (unknown) corresponds to the amount of competitor mRNA (known).
), this did not reach significance. Levels of O 2 Ϫ in another rat strain, the Sprague-Dawley, were similar to those observed in WKY 1.27Ϯ0.08 nmol ⅐ min Ϫ1 ⅐ mg
Ϫ1
(males only). Removal of the endothelium had no effect on O 2 Ϫ generation in either male or female WKY (Figure 3a) Treatment with L-NAME had effects similar to removing the endothelium. In WKY, O 2 Ϫ generation was unaffected by treatment, whereas in SHRSP, levels were significantly reduced, as shown in Figure 3b . In male SHRSP, levels were 4.13Ϯ0. 17 Figure  4b ). In contrast, oxypurinol, an inhibitor of xanthine oxidase, had no effect on O 2 Ϫ generation in either SHRSP or WKY (Figure 4b ).
Expression of eNOS in Thoracic Aorta
As shown in Figure 5a , eNOS mRNA expression (fg/100 ng ϮSEM) was significantly greater in SHRSP (308Ϯ49) compared with WKY (84.9Ϯ14) (95% CI: 107, 339; Pϭ0.002). Within the SHRSP, eNOS mRNA expression was significantly greater in males (417Ϯ43) compared with females (170Ϯ12) (95% CI: 123, 371; Pϭ0.005), and within the WKY there was a tendency for greater eNOS expression in males (113Ϯ17) compared with females (49.2Ϯ3.8) 95% CI: 16, 112; (Pϭ0.02), but this failed to achieve statistical significance when corrected for triple comparisons.
Western Blotting for eNOS
Comparison of the amount of NO synthase protein between WKY and SHRSP males is shown in Figure 5b . The aortas from SHRSP were found to have significantly higher levels than the aortas from the WKY. The ratios of eNOS to ␣-actin in SHRSP and WKY were 5.24Ϯ0.43 and 3.06Ϯ0.22, respectively (Pϭ0.02, 95% CI 0.638, 3.722; nϭ4).
Discussion
In this study we have shown both increased eNOS mRNA expression and increased O 2 Ϫ production in SHRSP compared with WKY. Moreover, in this model of genetic hypertension we have identified the cellular and enzyme sources of the O 2 Ϫ excess as the endothelial cells and eNOS, respectively. Despite the increase in expression of mRNA for eNOS and the increased enzymatic activity of eNOS previously demonstrated by ourselves, 5 NO availability has been shown to be reduced. This was manifest in a decrease in basal but not agonist-stimulated NOmediated responses. 5 Thus it appears that the excess O 2 Ϫ generation more than balances the increase in NO production leading to a net decrease in functional NO availability. Enhanced eNOS expression together with increased O 2 Ϫ generation has also been reported in Sprague-Dawley rats made hypertensive by aortic banding. 7 It is tempting to speculate that the enhanced eNOS expression is a compensatory mechanism related to the increase in O 2 Ϫ generation. However, an inverse relation between eNOS expression and O 2 Ϫ generation is not always observed. In studies in mature 16-month animals, Bauersachs et al 16 found no increase in eNOS expression in SHR thoracic aorta despite an increased O 2 Ϫ generation. The studies described here using L-NAME and L-NMMA suggest that in the SHRSP O 2 Ϫ is generated by eNOS. There are other reports of NOS producing O 2 Ϫ . Purified rat nNOS has been shown to produce O 2 Ϫ in a reaction that is inhibited by L-NAME but not L-NMMA. 17 Heinzel et al 18 showed that purified nNOS can produce hydrogen peroxide under conditions of low L-arginine concentrations. Xia et al 19 confirmed this finding in intact human kidney cells stably transfected with the rat nNOS gene. Huk and colleagues 20 suggest that O 2 Ϫ may be generated from eNOS during reperfusion after ischemia. In these studies in rabbit hind limb, administration of L-arginine before ischemia reperfusion reduced the subsequent release of O 2 Ϫ . Despite the suggestion that eNOS production of O 2 Ϫ may be related to low levels of L-arginine, the addition of exogenous L-arginine had no effect on O 2 Ϫ generation in either SHRSP or WKY in our studies. Suboptimal concentrations of tetrahydrobiopterin may also favor eNOS catalyzed production of O 2 Ϫ . 21 Recently, Cosentino and colleagues 22 have shown tetrahydrobiopterin to attenuate the O 2 Ϫ generation, which occurred in response to the calcium ionophore A23187 in aortas from young (4-week) SHR. We also saw an attenuation of O 2 Ϫ production in vessels from SHRSP that were incubated with tetrahydrobiopterin, suggesting a critical role for tetrahydrobiopterin in regulating eNOS. The exact mechanism whereby eNOS generates O 2 Ϫ is uncertain. However, molecular cloning of NO synthase revealed close amino acid sequence homology between NO synthase and cytochrome P 450 reductase, a known cellular source of O 2 Ϫ . 23 In hypertension caused by aortic banding, increased O 2 Ϫ production is reported to be an early event that reached a maximum within 2 weeks of surgery. 7 In that study O 2 Ϫ production was not inhibited by L-NAME, and the source of the excess O 2 Ϫ was not identified. Increased O 2 Ϫ production has also been observed in angiotensin IImediated hypertension. In this model of hypertension L-NMMA had no effect on O 2 Ϫ generation and the source of the excess O 2 Ϫ appeared to be membrane bound vascular NADH/NADPH oxidases. 8 In our animals the major source of vascular smooth muscle O 2 Ϫ appeared to be NADH/NADPH oxidases, as illustrated by the attenuation of O 2 Ϫ generation in the presence of DPI. NADPH is a cofactor for eNOS. Thus the proportionally greater reduction in O 2 Ϫ generation in SHRSP compared with WKY is likely to be due to inhibition of O 2 Ϫ production by eNOS, in addition to inhibition of NADH/NADPH oxidases in vascular smooth muscle in SHRSP. Oxypurinol had no effect on O 2 Ϫ generation in either SHRSP or WKY, suggesting that the xanthine oxidase pathway did not contribute to O 2 Ϫ in these animals. O 2 Ϫ generation was not completely abolished in the tissues incubated with 100 mol/L DPI for 1 hour. The effects of DPI were dose and time dependent. It is possible that complete inhibition of NADH/NADPH oxidase was not achieved. Alternatively, there are a number of other potential sources of O 2 Ϫ including aldehyde oxidase, dihydro-orotic dehydrogenases, flavin dehydrogenases, peroxidases, and auto-oxidation compounds such as catecholamines. 24 In WKY animals we observed a significant gender effect on O 2 Ϫ levels, O 2 Ϫ being greater in males than females. This would be consistent with the higher blood pressure in males. Brandes and Mugge 25 also found that levels of O 2 Ϫ were higher in male than female Wistar rats. In the SHRSP O 2 Ϫ levels tended to be higher in the males than the females, but this difference was not significant. It is probable that any gender effect was overwhelmed by the much larger hypertensive effect. One explanation for the gender effect would be that the higher levels of estrogen in the females resulted in increased scavenging of O 2 Ϫ . Arnal et al 26 have shown the synthetic estrogen ethynyl estradiol to increase release of bioactive NO by inhibiting superoxide anion production in cultured bovine endothelial cells, whereas Kleinert et al 27 have shown increased transcription of human eNOS gene on treatment with estrogens in culture.
In summary, we have shown O 2 Ϫ generation to be increased in SHRSP. The tissue and enzymatic sources of this excess O 2 Ϫ appear to be the endothelium and eNOS, respectively. The increase in O 2 Ϫ generation in SHRSP could contribute to the decreased availability of basal NO observed in this model of genetic hypertension.
Our findings reconcile previous controversies that surrounded molecular and functional analysis of endothelial function in the SHRSP and related models of genetic hypertension. Despite an excessive production of the eNOS mRNA combined with the increased eNOS protein levels, there is NO-dependent endothelial dysfunction that is best explained by an excess of O 2 Ϫ generated by the eNOS enzyme within the endothelial cells.
